using semaglutide and tirzepatide together vs for Weight Loss Choosing Between Tirzepatide and Semaglutide

Tran HTN, Ang KS, Chevrier M, et al

Months 6 to 12: Long-term users who have made consistent dietary and lifestyle changes alongside medication report continued body composition improvements and weight maintenance

GLP-1 therapies like Ozempic have also been shown to lower the risk of heart and kidney disease, leading to additional FDA approvals for heart and kidney protection

According to a large, real-world database study, the use of glucagon-like peptide 1 receptor agonists (GLP1RA) was associated with improved inflammatory bowel disease (IBD)-related outcomes among patients with ulcerative colitis (UC) and Crohns disease (CD)